{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:05Z","timestamp":1791011945909,"version":"4.1.0"},"reference-count":50,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2,1]]},"DOI":"10.1210\/jc.2009-1603","type":"journal-article","created":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T02:47:42Z","timestamp":1259981262000},"page":"578-585","source":"Crossref","is-referenced-by-count":201,"title":["Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active"],"prefix":"10.1210","volume":"95","author":[{"given":"Takashi","family":"Shimada","sequence":"first","affiliation":[{"name":"Endocrine Unit (T.S., H.J.), Departments of Medicine and Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"},{"name":"Innovative Drug Discovery Laboratories (T.S., I.U., Y.Y.), Kyowa Hakko Kirin Co., Ltd., Gunma 370-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Urakawa","sequence":"additional","affiliation":[{"name":"Innovative Drug Discovery Laboratories (T.S., I.U., Y.Y.), Kyowa Hakko Kirin Co., Ltd., Gunma 370-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[{"name":"Nephrology Unit (T.I., M.E.), Departments of Medicine and Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Innovative Drug Discovery Laboratories (T.S., I.U., Y.Y.), Kyowa Hakko Kirin Co., Ltd., Gunma 370-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Epstein","sequence":"additional","affiliation":[{"name":"Nephrology Unit (T.I., M.E.), Departments of Medicine and Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wesseling-Perry","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (K.W.-P., I.B.S.), David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension (M.W.), Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[{"name":"Endocrine Unit (T.S., H.J.), Departments of Medicine and Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Ju\u0308ppner","sequence":"additional","affiliation":[{"name":"Endocrine Unit (T.S., H.J.), Departments of Medicine and Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"},{"name":"Pediatric Nephrology Unit (H.J.), Departments of Medicine and Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113503829200_R1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00424-003-1084-1","article-title":"Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na\/Pi transporter","volume":"446","author":"Segawa","year":"2003","journal-title":"Pflu\u0308gers Arch"},{"key":"key\n\t\t\t\t2019041113503829200_R2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2008020177","article-title":"Type IIc sodium-dependent phosphate transporter regulates calcium metabolism","volume":"20","author":"Segawa","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113503829200_R4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"The ADHR Consortium","year":"2000","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113503829200_R5","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113503829200_R6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041113503829200_R7","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113503829200_R8","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113503829200_R9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113503829200_R10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113503829200_R11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113503829200_R12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113503829200_R13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00774-004-0589-9","article-title":"The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome","volume":"23","author":"Yamamoto","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t2019041113503829200_R14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R15","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113503829200_R16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2008-0326","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis","volume":"94","author":"Wesseling-Perry","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113503829200_R17","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"key\n\t\t\t\t2019041113503829200_R19","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113503829200_R20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factors (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019041113503829200_R21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutie\u0301rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113503829200_R22","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R23","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113503829200_R25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.jrn.2007.12.002","article-title":"Public health approach to addressing hyperphosphatemia among dialysis patients","volume":"18","author":"Sehgal","year":"2008","journal-title":"J Ren Nutr"},{"key":"key\n\t\t\t\t2019041113503829200_R27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Page\u0300s","year":"2004","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113503829200_R28","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113503829200_R29","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113503829200_R30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00424-007-0231-5","article-title":"Biological activity of FGF-23 fragments","volume":"454","author":"Berndt","year":"2007","journal-title":"Pflugers Arch"},{"key":"key\n\t\t\t\t2019041113503829200_R31","first-page":"78A","article-title":"C-terminal fragment of fibroblast growth factor (FGF) 23 inhibits renal phosphate (Pi) excretion as an FGF23 antagonist by displacing FGF23 from its receptor","volume":"19","author":"Hu","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113503829200_R32","first-page":"507","article-title":"Measurement of parathyroid hormone","author":"Ju\u0308ppner","year":"2006","journal-title":"In: Seibel M, Robins S, Bilezikian J, eds. Dynamics of bone and cartilage metabolism. 2nd ed. Philadelphia: Elsevier;"},{"key":"key\n\t\t\t\t2019041113503829200_R33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113503829200_R34","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113503829200_R35","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113503829200_R36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s001090050258","article-title":"Early growth response factor 1: a pleiotropic mediator of inducible gene expression","volume":"76","author":"Khachigian","year":"1998","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t2019041113503829200_R37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(93)90660-I","article-title":"The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage","volume":"72","author":"Nguyen","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019041113503829200_R38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1755.2003.00700.x","article-title":"Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy","volume":"63","author":"Goodman","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113503829200_R39","first-page":"1697","article-title":"The renal osteodystrophies","author":"Wesseling","year":"2005","journal-title":"In: DeGroot L, Jameson J, eds. Endocrinology. 5th ed. Philadelphia: WB Saunders;"},{"key":"key\n\t\t\t\t2019041113503829200_R40","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1523-1755.2005.00493.x","article-title":"Structure of non-(1\u201384) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism","volume":"68","author":"D'Amour","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113503829200_R41","first-page":"1377","article-title":"Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development","author":"Ju\u0308ppner","year":"2005","journal-title":"In: DeGroot L, Jameson J, eds. Endocrinology. 5th ed. Philadelphia: WB Saunders;"},{"key":"key\n\t\t\t\t2019041113503829200_R42","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113503829200_R43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00774-005-0625-4","article-title":"Comparison of two assays for fibroblast growth factor (FGF)-23","volume":"23","author":"Ito","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t2019041113503829200_R44","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI119276","article-title":"Pex\/PEX tissue distribution and evidence for a deletion in the 3\u2032 region of the Pex gene in X-linked hypophosphatemic mice","volume":"99","author":"Beck","year":"1997","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113503829200_R45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113503829200_R46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Page\u0300s","year":"2005","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2019041113503829200_R47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders","volume":"83","author":"Frishberg","year":"2005","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t2019041113503829200_R48","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1210\/en.2005-0431","article-title":"Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed","volume":"146","author":"Larsson","year":"2005","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113503829200_R49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113503829200_R50","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/2\/578\/9065479\/jcem0578.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T12:44:33Z","timestamp":1634301873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/2\/578\/2596716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,1]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-1603","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,1]]}}}